SWARTZ ROBIN (Chief Operating Officer) received a stock award from VOYAGER THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2026ACC: 0001104659-26-012675
Officer· Chief Operating Officer
Since Feb 2022
+255K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
255K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
26.5%
2/6/2026
169.65K→214.65K
Total
Net shares
+45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | A · Award | +45K | — | — | 26.5% | 169.65K | 214.65K |
| Total | +45K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
210K shares
Shares
+210K
Strike price
3.68
Held after
210K
Exercisable
—
2/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock210K shares | 2/6/2026 | A · Award | +210K | 3.68 | — | 210K |